Filing Details

Accession Number:
0001209191-16-127051
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-10 16:08:31
Reporting Period:
2016-06-09
Filing Date:
2016-06-10
Accepted Time:
2016-06-10 16:08:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
819050 Vical Inc VICL Biological Products, (No Disgnostic Substances) (2836) 930948554
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198238 B Vijay Samant 10390 Pacific Center Court
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock $.01 Par Value Acquisiton 2016-06-09 15,700 $4.72 112,632 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents a weighted average purchase price per share. The prices actually paid ranged from $4.65 to $4.78. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
  2. Such number reflects the 1-for-10 reverse stock split of the issuer's common stock on May 26, 2016, resulting in the Reporting Person's ownership of 872,394 fewer shares of common stock.